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Functional Mutation of SMAC/DIABLO,
Encoding a Mitochondrial Proapoptotic Protein,
Causes Human Progressive Hearing Loss DFNA64
Jing Cheng,1,10 Yuhua Zhu,1,10 Sudan He,2,3 Yanping Lu,4 Jing Chen,1 Bing Han,1 Marco Petrillo,5
Kazimierz O. Wrzeszczynski,6 Shiming Yang,1 Pu Dai,1 Suoqiang Zhai,1 Dongyi Han,1
Michael Q. Zhang,6 Wei Li,7 Xuezhong Liu,8 Huawei Li,9 Zheng-Yi Chen,5 and Huijun Yuan1,*
SMAC/DIABLO is amitochondrial proapoptotic protein that is released frommitochondria during apoptosis and counters the inhibitory
activities of inhibitor of apoptosis proteins, IAPs. By linkage analysis and candidate screening, we identified a heterozygous SMAC/
DIABLOmutation, c.377C>T (p.Ser126Leu, refers to p.Ser71Leu in themature protein) in a six-generationChinese kindred characterized
by dominant progressive nonsyndromic hearing loss, designated as DFNA64. SMAC/DIABLO is highly expressed in human embryonic
ears and is enriched in the developing mouse inner-ear hair cells, suggesting it has a role in the development and homeostasis of hair
cells. We used a functional study to demonstrate that the SMAC/DIABLOS71L mutant, while retaining the proapoptotic function, triggers
significant degradation of both wild-type and mutant SMAC/DIABLO and renders host mitochondria susceptible to calcium-induced
loss of themembrane potential. Our work identifies DFNA64 as the human genetic disorder associated with SMAC/DIABLOmalfunction
and suggests that mutant SMAC/DIABLOS71L might cause mitochondrial dysfunction.Introduction
Hearing loss affects an estimated 28 million Americans,
27.8 million Chinese, and 22.5 million Europeans.1–3 It
was estimated that several-hundred genes could be associ-
ated with this sensory deficit in humans. This high genetic
heterogeneity could reflect the anatomical and functional
complexity of the inner ear. In the past two decades, exten-
sive research efforts on the genetics of hearing loss led to
the mapping of 143 loci and the identification of 62 genes
responsible for nonsyndromic hearing loss (Hereditary
Hearing Loss homepage; see Web Resources). The identifi-
cation of genes for autosomal-dominant nonsyndromic
hearing loss (DFNA) will be important for understanding
age-related hearing impairment, the most prominent
form of hearing loss. Gene mutations associated with
late-onset progressive disorders are most likely to result
in less drastic changes in protein structure and function.
The progressive nature of these diseases could then be ex-
plained by a gradual increase in the ratio of damaged to
normal proteins or changes in protein level.4 The genes
involved in human nonsyndromic hearing loss encode
proteins with a wide spectrum of biological structures
and functions, including transcriptional regulation, Kþ re-
cycling, the cytoskeleton, cell-cell junctions, membrane
transport, the extracellular matrix, and other structural
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is a major cause of hearing loss in mammals.7–9 A recent
study showed that Bak, a proapoptotic protein, is involved
in age-related hearing loss in mice.10 However, none of the
62 human genes involved in nonsyndromic hearing loss
is known to have a proapoptotic function. Only TJP2
(MIM 607709) was recently reported to participate in
apoptosis pathways by altering expression of apoptosis
genes through genomic duplication and overexpression
in DFNA51 (MIM 613558).11 In 2000, Du et al. identified
SMAC (second mitochondria-derived activator of caspase,
MIM 605219, accession number AAF87716.1), a pro-
apoptotic mitochondrial protein that promotes caspase
activation by relieving IAP inhibition.12 Verhagen et al.
identified the murine homolog of SMAC and named it
DIABLO (direct inhibitor of apoptosis protein binding
protein with a low pI).13 SMAC/DIABLO (hereafter referred
to as DIABLO, which has been approved by the HUGO
Gene Nomenclature Committee) is synthesized as a 239
amino acid precursor molecule. The amino-terminal 55
residues serve as the mitochondria-targeting sequence,
which is removed after the Smac protein is imported
into mitochondria intermembrane space. Chai et al.
determined the crystal structure of DIABLO, which re-
vealed that DIABLO must form a homodimer to interact
with IAPs. A particular N-terminal motif, consisting of
four amino acids, Ala-Val-Pro-Ile, is responsible for theChina; 2National Institute of Biological Sciences, No.7 Science Park Road,
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interaction with IAPs. DIABLO interacts with the BIR2 and
BIR3 domains of XIAP, allowing the release of caspase-3
and caspase-9, respectively.14
Given its central role in regulating apoptosis, it is
expected that DIABLO dysfunction might underlie the
pathogenesis of some human diseases. However, no
DIABLO mutation that is associated with any human
genetic disorders has previously been identified. In this
paper, we report the identification of a DIABLO missense
mutation that underlies autosomal-dominant hearing
loss, designated as DFNA64, in a six-generation Chinese
kindred. We report a functional study to illustrate that
the identified mutation causes degradation of mutant
and wild-type DIABLO; this degradation is likely to lead
to mitochondrial dysfunction and contributes to DFNA64.Material and Methods
Clinical Evaluations
The family HN-W078 was ascertained from the Henan province
of Mainland China. All the procedures were approved by the
Ethics Reviewing Committee of the Chinese PLA General Hospital
and were carried out only after written informed consent was
obtained from each individual and/or parents of the children.
The medical history was obtained by use of a questionnaire
regarding the following aspects: subjective degree of hearing
loss, age at onset, evolution, symmetry of the hearing impairment,
hearing aids, presence of tinnitus and vertigo, medication, noise
exposure, pathologic changes in the ear, and other relevant
clinical manifestations. Otoscopy, physical examination, and
pure-tone audiometry (at frequencies from 250 to 8000 Hz) were
performed. Immittance testing was applied so that middle-ear
functions could be evaluated.Linkage Analysis
Blood samples (3 ml) were drawn from 33 participants so that
genomic DNA could be extracted with the Genomic DNA isolation
kit (QIAGEN). A genome-wide scan was performed for a selected
18 subjects via Affymetrix Genome-Wide Human SNP Array 5.0
containing 57,244 SNPs. Multipoint parametric linkage analysis
was performed with Merlin v. 1.0 so that parametric LOD scores
could be calculated. Penetrance values used for the dominant
model were 0.01, 0.90, and 0.90 for the wild-type homozygote,
mutant heterozygote, and mutant homozygote, respectively.
We assumed a disease allele prevalence frequency of 0.0001 and
a phenocopy rate of 1%. Fine mapping was performed with ten
microsatellite markers selected from Marshfield chromosome
12 map. The alleles were assigned with Genescan and Genotyper
Software (Applied Biosystems, USA). Linkage analysis was per-
formed with the LINKAGE 5.1 software package. The two-point
LOD score between the deafness locus and each marker was
calculated under a fully penetrant autosomal-dominant mode of
inheritance, and the disease allele frequency was set to 0.0001.
The meiotic recombination frequencies were considered to be
equal for males and females.Mutation Analysis
Direct sequencing was used for mutation screening. Primers were
designed to amplify all exons and flanking intronic splicing sitesTheof genes from genome DNA. Sequences of these primers are given
in Table S1, available online. The accession numbers and versions
of candidate genes are listed in Table S2.Quantitative RT-PCR
Expression of DIABLO transcript in different human embryonic
tissues at week 17 of pregnancy was evaluated by real-time quan-
titative RT-PCR. All the procedures were approved by the Ethics
Reviewing Committee of the Chinese PLA General Hospital. Total
RNA was purified with the Trizol method (Invitrogen) and treated
with DNase I (QIAGEN). Total RNA (1 mg) was reverse transcribed
with the SuperScript III First-Strand Kit (Invitrogen). Amplimer
levels were quantified continuously with the SYBR Green system
(Applied Biosystems) for analysis of transcript expression of
tissues, and the Taq-ManMGB probe system (Applied Biosystems)
was applied for the analysis of the transcription of wild-type
and mutant DIABLO in HeLa cells. Gene expression levels were
calculated with the 2(DDCT) method. Target-gene expression was
normalized to b-actin expression.Cell-Viability Assay
Cell-survival analysis was performed with the Cell Titer-Glo Lumi-
nescent Cell-Viability Assay kit (Promega) according to manufac-
turer instruction with minor modification. In brief, 20 ml of Cell
Titer-glo reagent was added to the cell culture medium. Lumines-
cent reading was carried on Tecan SpectraFluor Plus reader (Tecan).Site-Directed Mutagenesis and Recombinant-Protein
Preparation
We generated point mutations by using the QuikChange Light-
ning Site-Directed Mutagenesis Kit (Stratagene).Immunoprecipitation
Cell lysates were incubated with M2 FLAG agarose beads (Sigma)
overnight at 4C. Beads were washed with lysis buffer containing
an additional 300 mM NaCl. The immunoprecipitants were
eluted off the beads with low pH elution buffer (Pierce) for
5 min at room temperature. Acid elution was neutralized by the
addition of a 1/20 volume of 1 M Tris-HCl (pH 9.4).Immunolot Analysis
Antibodies were used according to the manufacturer’s suggestion.
Immunoblot analysis was performed with a horseradish-
peroxidase-conjugated goat anti-rabbit immunoglobulin G and
enhanced chemiluminescence (ECL) immunoblotting detection
reagents (Sigma).Immunohistochemistry
Mouse inner-ear tissues from timed pregnancy were collected
via a previously described procedure.15 The use of animals
and the procedures involving tissue preparation were approved
by the Institutional Animal Care and Use Committee of the
Massachusetts Eye and Ear Infirmary. Standard procedures were
employed for staining cryosectioned mouse cochlear slides and
HeLa cells with the antibodies against the following antigens:
DIABLO antibody [Y12] (1:200 for HeLa cells, 1:1000 for cochlear
slides, Abcam, ab32023), MitoTracker Mitochondrion-Selective
Probes (1:5000, Molecular Probe), and DAPI (13 , Molecular
Probe).American Journal of Human Genetics 89, 56–66, July 15, 2011 57
Figure 1. Pedigree of Chinese Family HN-W078 with Dominant Progressive Hearing Loss and a Combined Audiogram of Affected
Subjects
Affected subjects are denoted in black. The proband is indicated by an arrow. On the basis of the audiograms of the affected subjects, the
severity of hearing impairment appears to be correlated with the individual’s age.Smac-XIAP Binding Assay
Pellet cells were centrifuged from culture media and were washed
with phosphate-buffered saline (PBS) and solubilized in 200 ml ice-
cold extraction buffer (50 mM HEPES [pH 7.5], 10 mM KCl, 5 mM
EGTA, 1mMMgCl2, 0.2% Chaps, and 0.2 mMDTT) at a density of
23 108 cells/ml. The cell pellet was snap frozen in liquid nitrogen
and stored at 80C. Thawed cell were extracted and centrifuged
at 14,000 3 g for 15 min at 4C. Then, 10 ml of cell extract was
added to tubes containing bovine heart cytochrome c (Sigma,
5 ml of a 1 mg/ml stock), dATP (Sigma, catalog # D6500, 5 ml of
a 5.0mM stock adjusted to pH 7.5 with KOH), and 5 ml of recombi-
nant XIAP protein with or without 5 ml recombinant wild-type
and mutant DIABLO. The samples were incubated in a 37C water
bath for 60 min. The cleaved fractions were detected by immuno-
blot with caspase-3 antibody (Cell signaling, 9662).
Knockdown of Smac by siRNA Transfection
MISSION esiRNAs (Sigma) are endoribonuclease-prepared siRNA
pools comprised of a heterogeneous mixture of siRNAs that all
target the same mRNA sequence. MISSION siRNA was transfected
according to the manufacturer’s instructions.
Live-Cell Imaging of Mitochondrial Membrane
Permeability
HeLa cells were plated in cultured media (DMEM from Hyclone,
10% FBS, and 1% P/S). Fresh media containing 25 nM TMRM58 The American Journal of Human Genetics 89, 56–66, July 15, 2011(T668, Invitrogen) and 100 nM mitoTracker Green (M7514,
Invitrogen) was added, and incubation followed for 25 min at
37C under protection from light. Warm media containing
200 mM CaCl2 and 20 mM A23187 (C7522, Sigma) were added.
Images were acquired at every 10 min thereafter with a ZEISS
403/1.42 confocal microscope. Each image was comprised of
eight z stacks in which each section was 1 mM in depth.Results
Family and Clinical Evaluations
The pedigree of family HN-W078, which spans six genera-
tions and comprises 127 members, is consistent with
an autosomal-dominant inheritance pattern (Figure 1).
Thirty-three family members, including 18 affected
members and 15 normal individuals, participated in this
study. Responses to questionnaires indicated that the
age of onset of hearing impairment in this family
varied from 12 to 30 years (the average age of onset was
22 years). In 18 affected subjects, hearing impairment
was symmetric. The severity of hearing impairment varied
from severe to moderate to mild hearing according to
the subjects’ audiograms. The severity of hearing impair-
ment appears to be correlated with the individual’s age
Table 1. Summary of Clinical Data for Some of the Affected Individuals of Family HN-W078
Patient Gender
Age (Years)
Use of
Aminoglycoside
Hearing Test PTA*(dB HL)
Audiogram
Shape
Level of Hearing
Impairment* Vertigo Tinnitus
At
Testing
At
Onset
Left
Ear
Right
Ear
II:7 female 76 24 no 80 88 flat severe no yes
III:10 male 60 22 no 79 80 flat severe no yes
III:13 male 59 26 no 110 76 flat severe no yes
III:15 female 53 20 no 66 66 flat moderate no yes
III:19 female 52 30 no 60 62 flat moderate no no
IV:3 male 52 24 no 61 68 flat moderate no yes
IV:6 male 49 24 no 63 64 flat moderate no yes
IV:8 male 40 23 no 71 71 flat severe no no
IV:10 male 55 20 no 76 78 flat severe no yes
IV:24 male 30 15 no 70 70 flat severe no yes
IV:26 female 26 20 no 58 55 sloping moderate no yes
IV:31 male 18 12 no 48 48 flat moderate no yes
IV:33 male 33 26 no 60 69 flat moderate no yes
IV:35 female 31 20 no 58 59 flat moderate no yes
V:13 male 27 23 no 53 54 sloping moderate no no
V:27 female 23 16 no 41 44 flat moderate no no
* The degree of hearing loss was defined according to pure-tone averages (PTAs), which were based on the frequencies 500, 1,000, and 2,000 Hz.(Table 1). Overall, the audiograms of affected members
have a flat contour (Figure 1). High-frequency tinnitus
was reported in 73% of affected members at the onset of
hearing loss. Audiologic evaluation of the family members
demonstrated normal immittance testing and bone
conduction values that equal the air conduction measure-
ments, suggesting a sensorineural hearing impairment.
Comprehensive family medical histories and clinical
examination of these individuals showed no other clinical
abnormalities, including diabetes, cardiovascular diseases,
visual problems, or neurological disorders. Inner-ear mal-
formations were ruled out by computer tomography,
which was normal in the proband of this family.
Mapping of DFNA64 Locus
Multipoint genome-wide linkage analysis yielded a posi-
tive region with single-nucleotide polymorphism (SNP)
markers on chromosome 12q24.31–12q24.32 (chr12:
121,924,854 128,895,742) between markers rs7955747
and rs10773539 and a maximum logarithm of the odds
(LOD) score of 5.66 (Figure 2A). Fine mapping employing
extensive microsatellite markers placed a genetic interval
between markers D12S86 and D12S1612 (Figure 2B; see
also Figure S1). The combination of these two methods
allowed us to narrow down the critical interval harboring
a candidate locus between the markers rs7955747 and
D12S1612, which did not overlap with the flanking
DFNA25 (MIM 605583) or DFNA41 (MIM 608224) locusThe(Figure 2C).16,17 Thus, we identified a dominant deafness
locus, designated as DFNA64 by the HumanGenomeOrga-
nization (HUGO) Gene Nomenclature Committee.
Identification of a Mutation in the DFNA64 Family
The mapped DFNA64 locus spans a physical distance of
3.09 Mb. More than 61 RefSeq genes have been identified
in this interval. Sequence analysis of six candidate genes
selected from the Morton Cochlear EST Database,18
PSMD9 (MIM 603146, 26S proteasome subunit), CDK2AP1
(MIM 602198, functions in the oncogenic process),
DIABLO (MIM 605219, functions in the mitochondrial
apoptotic pathway), KDM2B (MIM 609078, putative tumor
suppressor), ZCCHC8 (gene ID 55596, GSK-3 substrate,
functions in RNA metabolism), and SBNO1 (gene ID
55206, functions in the Notch signaling pathway), led to
the identification of a heterozygous C-to-T transition at
position 377 in exon 5 (NM_019887.4: c.377 C>T, Figures
2D and 2E). This transition resulted in a p.Ser126Leu
(p.Ser71Leu in mature protein) substitution in DIABLO.
The Ser residue at position 126 in DIABLO is conserved
across human, rat, mouse, bovine, ornithorhynchus,
chicken, andXenopus lineages (Figure 2F). EcoR I restriction
analysis demonstrated that the c.377 C>T mutation
completely cosegregated with hearing loss in family
HN-W078 and was absent in 1000 unrelated Chinese con-
trol chromosomes. The penetrance of hearing loss in this
family is 100% on the basis of the data from investigatedAmerican Journal of Human Genetics 89, 56–66, July 15, 2011 59
Figure 2. Mapping Interval and Mutation Analysis of the Chinese Family HN-W078
(A) Genome-wide linkage analysis with SNP markers defined an interval between markers rs7955747 and rs10773539 and gave
a maximum HLOD score of 5.66.
(B) Fine mapping of the candidate region with microsatellite markers defined an interval between markers D12S86 and D12S1612 and
gave a maximum LOD score of 5.35.
(C) Idiogram of the DFNA64 locus on chromosome 12 with flanking markers and candidate genes. The loci of DFNA25, DFNA41, and
DFNA48 are also indicated.
(D) The genomic structure of different DIABLO transcripts. The position of the DFNA64 mutation in exon 5 is shown. DIABLO has four
different transcripts, but only two of them encode proteins. NM_019887.4 is the longest transcript and encodes NP_063940.1.
NM_138929.3 encodes a shorter isoform, NP_620307. Both transcripts harbor exon 5, where the c. 377C>T mutation is located.
(E) DNA sequence chromatograms showing a heterozygous c.377C>T mutation in DIABLO in DFNA64 individuals are compared to
those of wild-type controls.
(F) Conservation analysis showing that Ser126 in DIABLO is conserved across human, rat, mouse, bovine, ornithorhynchus, chicken,
and Xenopus lineages.individuals. All variants identified in six candidate genes in
this family are listed in Table S2. We have screened 223
Chinese families or sporadic subjects with late-onset
hearing loss (<40 years).Wedidnot find anyDIABLOmuta-
tion in those samples.
DIABLO Is Highly Expressed in the Human andMouse
Inner Ear
To investigate the role of DIABLOmalfunction in DFNA64,
we first examined the expression of DIABLO in different
human embryonic tissues by using real-time quantitative
RT-PCR. DIABLO mRNA was detected broadly; the highest
expression was in the testis, adrenal gland, and ears, there
was moderate expression in the brain, eyes, liver, kidney,
lung, and spinal cord, and there was low expression in
the spleen (Figure 3A). We next studied the production
of Diablo in the developing mouse inner ear with an60 The American Journal of Human Genetics 89, 56–66, July 15, 2011anti-DIABLO antibody. Diablo was widely expressed at
a low level in the developing mouse cochlea (Figure 3C).
However, Diablo was significantly upregulated in hair cells
from E18.5 to P0 and was subsequently downregulated. A
secondary antibody control did not produce any discern-
able staining pattern (data not shown). The extended
distribution of Diablo at different stages of development
in the mouse inner ear and the particular enrichment in
hair cells suggested that Diablo functions in the develop-
ment and homeostasis of the inner ear and in hair cells
in particular.
Mutant DIABLO Has Similar Proapoptotic Activity
to Wild-Type Protein
We carried out bioinformatics analysis to predict the
likely functional impact of the DIABLOS71L mutant on
the basis of the crystal structure of the wild-type DIABLO
Figure 3. Expression Profiling of DIABLO in the Developing Human and Mouse Inner Ear
(A) Expression of DIABLO transcript in different human embryonic tissues at week 17 of pregnancy was evaluated by real-time quanti-
tative RT-PCR. Data are means5 SD of three independent experiments.
(B) Schematic representation of the Corti’s organ in the inner ear. The sensory epithelium of the cochlea consists of inner and outer hair
cells. Supporting cells of the Corti’s organ include Hensen’s, Claudius’s, Deiter’s, and Boettcher’s cells.
(C) Production of DIABLO in the developing mouse cochlea. (I) Cytoplasmic distribution of DIABLO was weakly detected ubiquitously
in developing cochlea, including the nascent inner hair cell (IHC) at the base, at E15.5. (II) By E18.5, DIABLO production was signifi-
cantly elevated in both inner and outer hair cells (IHCs and OHCs), in particular in the cytoplasm above the nuclei. DIABLO was
also readily detected in other cell types, including the greater epithelial ridge (GER). (III) DIABLO production was persistently higher
in cochlear hair cells at P0 than in surrounding cells. More than three OHCs were present in the image because of the section angle.
(IV) By P6, DIABLO was downregulated to a level that was indistinguishable from that of the GER. Myo7a: myosin VIIa that labels
hair cells. Magnification: 403.(PDB ID: 1FEW). It was indicated that Ser 71 is located at
a distance from the XIAP-binding site and on the opposite
end of the dimer interface (Figure 4A). Serine 71 might
form a hydrogen bond with neighboring Asp 75 and
thus stabilize the H1-H2 loop. Disruption of this hydrogen
bond could cause protein misfolding or structural damage
(data not shown). To test whether the DIABLOS71L muta-
tion would disrupt the DIABLO dimer formation and
DIABLO-XIAP binding activity, we expressed human
wild-type (DIABLOWT) and mutant DIABLO (DIABLOS71L)
in an E. coli system. The purified recombinant DIABLOS71L
and DIABLOWT showed similar profiles on Sephedex
200 columns and on native polyacrylamide gel electropho-
resis (PAGE), indicating that DIABLOS71L is able to form
a dimer (Figure 4B). We then investigated DIABLO-XIAP
binding activity by assessing caspase 3 activation in an
in vitro system. As shown in Figure 4C, procaspase 3 was
activated and cleaved into two fragments of P20 and P12
in activated HeLa cell extracts (lane 2); this activity
was blocked by the addition of purified recombinant
XIAP (lanes 3 and 4). The inhibition of procaspase 3
activation by XIAP was removed by further incubation
with DIABLOWT (lanes 5 and 6) or DIABLOS71L (lanes 9
and 10) in a dose-dependent manner. These observa-
tions demonstrated that DIABLOS71L does not jeopardize
DIABLO-XIAP binding activity. We further investigatedThethe effect of DIABLOS71L mutation on apoptosis in cultured
cells. As shown in Figure 4D, HeLa cells overexpressing
DIABLOWTor DIABLOS71L showed no significant difference
of cell viability when treated with several proapoptotic
agents, includingetoposide,ActinomycinD, and cisplastin,
indicating that DIABLOS71L does not give rise to an
increased apoptotic activity under these conditions.
Ectopically Expressed DIABLOS71L Triggered
Degradation of the Mutant and Wild-Type DIABLO
in a Heterodimeration-Dependent Way in HeLa Cells
To further investigate the effect of DIABLOS71L, we tagged
DIABLOWT and DIABLOS71L with FLAG and determined
the expression of DIABLO fusion protein in HeLa cells.
Similar levels of DIABLOWT and DIABLOS71L mRNA were
observed by quantitative real-time RT-PCR analysis (data
not shown). Surprisingly, when HeLa cells were transfected
with the same amount of DIABLOWT or DIABLOS71L plas-
mids, the protein level of DIABLOS71L was much lower
than that of the DIABLOWT transfected cells. Concurrently
with the decreased in DIABLOS71L, the endogenous
DIABLO showed a remarkable reduction in HeLa cells
transfected with DIABLOS71L as opposed to DIABLOWT.
Increasing expression of DIABLOS71L enhanced the degra-
dation of wild-type DIABLO (Figure 5A). These observa-
tions were further confirmed by immunohistochemistryAmerican Journal of Human Genetics 89, 56–66, July 15, 2011 61
Figure 4. Effects of the DIABLOS71L Mutant on Dimer Formation and DIABLO-XIAP Binding
(A) Structure analysis of the wild-type DIABLO (PDB ID: 1FEW) using PyMol program indicates Ser 71 in mature protein is located at the
end of the arch-shaped H1 helix. Binding XIAP is in yellow. The dimer interface is indicated by an arrow.
(B) The purified recombinant DIABLOS71L and DIABLOWT showed the same characters on Sephedex-200 columns and on native
polyacrylamide gel electrophoresis (PAGE), indicating that DIABLOS71L is able to form a dimer. WT: wild-type, MT: DIABLOS71L mutant.
(C) DIABLO-XIAP binding activity assay. Procaspase 3 was activated and cleaved into two fragments of P20 and P12 when ctivated HeLa
cell extracts (lane 2) were added; this activation and cleavage were blocked by the addition of recombinant XIAP (lanes 3 and 4). The
inhibition of procaspase 3 activation by XIAP was removed by the addition of DIABLOWT (lanes 5 and 6) or DIABLOS71L (lanes 9 and
10). Neither 1 nor 10 ng DIABLOWT and DIABLOS71L was enough to antagonize the XIAP effect (lanes 7,8,11, and 12).
(D) Cell-viability assay. In HeLa cells overexpressing DIABLOWT or DIABLOS71L, no difference in cell death was observed after it
was triggered by etoposide, Actinomycin D, or cisplastin. Data are represented as mean 5 standard deviation of three independent
experiments.(Figure 5B). To determine whether the degradation was
specifically induced by the DIABLOS71L mutant, we gener-
atedDIABLON70I andDIABLOE72L constructs and expressed
them in parallel with DIABLOS71L in HeLa cells. In contrast
to what we observed with the DIABLOS71L mutant, we did
not observe the degradation of DIABLON70I, DIABLOE72L
mutants, or endogenous DIABLO in the transfected cells
(Figure 5C).
To test whether the degradation of endogenous DIABLO
depends on the heterodimer formation of DIABLOS71L-
endogenous DIABLO, we generated two constructs
with the double mutations DIABLOS71LþV26D and
DIABLOS71LþF33D, which have a defect in dimerization,
as described previously.14 As shown in Figure 5D,
DIABLOS71L as well as DIABLOWT formed dimers with
endogenous DIABLO, and two monomeric DIABLO
mutants (DIABLOS71LþV26D and DIABLOS71LþF33D) were
unable to interact with endogenous DIABLO. Consis-
tently, only DIABLOS71L and not DIABLOS71LþV26D or
DIABLOS71LþF33D induced the degradation of endogenous
DIABLO. These observations demonstrated that the expres-62 The American Journal of Human Genetics 89, 56–66, July 15, 2011sion of DIABLOS71L in the transfected HeLa cells leads to
degradation of both the mutant and endogenous DIABLO
through heterodimerization between them.
DIABLOS71L Renders Host Mitochondria Susceptible
to Calcium-Induced Loss of Membrane Potential
Active degradation of DIABLOS71L indicates that the
mutated protein might trigger mitochondrial stress. Mito-
chondrial membrane potential (Dc) is a sensitive marker
of mitochondrial function, and its reduction has been
associated with mitochondrial dysfunction.19 To assess
changes of DJ in situ, we used tetramethylrhodamine
methyl ester (TMRM), a monovalent cationic fluorescent
dye widely used for measuring DJ.20,21 In HeLa cells ex-
pressing DIABLOS71L, DJ rapidly collapsed in response to
calcium-induced mitochondria stress, whereas the integ-
rity of mitochondrial structure was preserved, as shown
by mitoTracker green staining (Figure 6B). Upon exposure
to the same stimuli, cells expressing DIABLOWT exhibited
intact Dc (Figure 6A). We further investigated whether
the increased sensitivity to mitochondrial stress was due
Figure 5. Expression and Degradation of the DIABLOS71L Mutant in HeLa Cells
(A) Immunoblot analysis showed that DIABLOS71L and endogenous DIABLO decreased in a dose-dependent manner in the HeLa cells
transfected with DIABLOS71L. Patterns of wild-type and mutant DIABLO did not change.
(B) Immunostaining shows a remarkable reduction of DIABLO in HeLa cells transfected with DIABLOS71L.
(C) DIABLOS71L, DIABLON70I, andDIABLOE72L mutants and DIABLOWTwere expressed in parallel in HeLa cells. The reduction of mutant
and endogenous DIABLO was observed only in DIABLOS71L-transfected HeLa cells.
(D) DIABLOS71L, DIABLOS71LþV26D, and DIABLOS71LþF33D mutants and DIABLOWT were expressed in HeLa cells. Similar levels of endo-
genous DIABLO were observed in cells transfected with DIABLOS71LþV26D, DIABLOS71LþF33D, and DIABLOWT, whereas endogenous
DIABLO was decreased only in cells transfected with DIABLOS71L. DIABLOS71L, DIABLOS71LþV26D, and DIABLOS71LþF33D mutants
were decreased in cell lysates (input, second, third, and forth lanes). Heterodimerization of DIABLOS71L with endogenous DIABLO
was indicated by the clear band of endogenous DIABLO in elutions from DIABLOS71L-FLAG-agarose beads (elution, second lane). There
was no detectable endogenous DIABLO pulled down from cells transfected with DIABLOS71LþV26D and DIABLOS71LþF33D (elution, third
and forth lanes). XIAP was detected in both inputs, and elutions confirmed that DIABLOS71L, DIABLOS71LþV26D, and DIABLOS71LþF33D
mutants bound to XIAP normally.to the expression of DIABLOS71L or to the loss of endoge-
nous DIABLO. As shown in Figure 6C, expression of
DIABLOS71LþV26D caused cells to loseDc, whichwas similar
to what occurred in the DIABLOS71-transfected cells,
whereas a significant decrease in the endogenous DIABLO
by RNA interference (Figure S2) had no effect on Dc
(Figure 6D). These results strongly suggest that the impair-
ment of mitochondrial membrane potential in the HeLa
cells transfected with DIABLOS71L is specifically caused
by the existence of DIABLOS71L, leading to the activation
of a degradation machinery for constant clearance of aber-
rant proteins.Discussion
In the present study, a heterozygous missense mutation,
c.377C>T, that is genetically linked to progressive, non-
syndromic, sensorineural hearing loss in an extended
Chinese DFNA64 family was identified inDIABLO. BecauseTheof the critical role of DIABLO in the apoptosis pathway,
it was tempting to speculate that the pathological mecha-
nism of DFNA64 might be associated with a gain of func-
tion in apoptosis in the inner ear. The possible gain of
function of apoptosis could be mediated by the following
mechanisms: (1) the DIABLOS71L mutant enhances the
binding of XIAP-DIABLO; (2) the normal degradation of
DIABLO is disrupted by the mutation, increasing the
protein level of DIABLOS71L; or (3) the DIABLOS71L mutant
enhances IAP auto-ubiquitination, increasing the degrada-
tion of IAPs. To test these hypotheses, we overexpressed
both wild-type and mutant DIABLO in HeLa cells and
used a cell-viability assay to compare their effects on
apoptosis. We did not detect discernable differences in
cell death induced by mutant or wild-type DIABLO. This
is consistent with the prediction by molecular modeling
that the p.Ser71Leu mutation is located at the end of the
arch-shaped H1 helix, far away from the binding site of
DIABLO-IAPs and the dimer interface, and thus might
not impact the apoptotic function of DIABLO significantly.American Journal of Human Genetics 89, 56–66, July 15, 2011 63
Figure 6. Mitochondrial Membrane-Potential
Assay
In HeLa cells transfected with DIABLOWT,
DIABLOS71L, DIABLOS71LþV26D, and siRNA, mito-
chondrial membrane potential was monitored
by the loss of tetramethylrhodaminemethyl ester
(TMRM) fluorescence after exposure to the
calcium ionophore A23187.
(A and C) Mitochondrial membrane potential
was preserved for at least 45 min after exposure
to A23187 in DIABLOWT and siRNA transfection.
(B and D) In HeLa cells expressing DIABLOS71L or
DIABLOS71LþV26D, a loss of mitochondrial
membrane potential was observed 15–45 min
after exposure to A23187. The integrity of mito-
chondrial structure was shown by immunostain-
ing with mitoTracker green. Experiments were
replicated three times with similar results.An alternative hypothesis is that DFNA64 might be
caused by an accumulation of DIABLOS71L protein that
forms aggregates in hair cells. Such a mechanism has
been described in neurodegenerative disorders, including
Alzheimer, Huntington, and Parkinson diseases.22
However, overexpression of the DIABLOS71L mutant in
HeLa cells did not lead to an increased level of aberrant64 The American Journal of Human Genetics 89, 56–66, July 15, 2011DIABLO by in immunoblot analysis. In
contrast, the protein level of DIABLOS71L
decreased with the time of expression.
Moreover, the endogenous wild-type
DIABLO was degraded in the DIABLOS71L-
expressing HeLa cells, and the degradation
of DIABLOWT is dependent on DIABLOS71L-
DIABLOWT dimerization. Although the
mechanism underlying degradation is yet
to be determined, these results demonstrate
that the DIABLOS71L mutant exhibits a
specific deleterious effect that can be recog-
nized and cleared by host cells, and such an
effect extends to native wild-type DIABLO
as a result of dimerization with the mutant
protein, leading to severe reduction of the
overall DIABLO level.
By quantitative RT-PCR and immunohis-
tochemistry, we have shown that DIABLO
was highly expressed in the human embry-
onic inner ear and that the protein level
was elevated in the developing mouse
hair cells; these results are consistent with
the potential function of DIABLO in
mammalian inner-ear development and
maintenance. The inner ear is a delicate
organ with a limited number of postmitotic
hair cells, whose differentiation and matu-
ration state has to be precisely controlled,
both for their survival and normal func-
tion. This is demonstrated by a dispropor-
tionally large number of hair cell genes in
which mutations cause hair cell develop-mental defects, malfunction, or cell death, leading to
hearing loss.
Mitochondria assume central functions, including ATP
production, calcium homeostasis, reactive oxygen species
generation, and apoptotic signaling, in cells. Inner-ear
hair cells and neurons are particularly dependent upon
proper mitochondrial function to support high-energy
demand and cell maintenance. Smith and colleagues
demonstrated that vulnerable neurons in the brains of
individuals with Alzheimer disease have increased mito-
chondrial degradation products, suggesting a greater turn-
over of mitochondria by autophagy and/or a reduction of
proteolytic turnover and resulting accumulation of prod-
ucts of mitochondrial degradation.23 In mouse models,
age-related hearing loss has been associated with an accu-
mulation of oxidative stress induced by reactive oxygen
species (ROS); mitochondria are a major source of ROS
generation and the site of ROS-induced damage.24 Given
our evidence that DIABLOS71L collapses the mitochondrial
membrane potential under stress and that DIABLOS71L is
associated with progressive hearing loss in the family
studied, it is highly likely that the defects caused by
DIABLOS71L might ultimately result in chronical mito-
chondrial dysfunction and thus lead to hair cell degenera-
tion and death. Because hair cells are long-lived terminally
differentiated cells, in vivo expression of DIABLOS71L is
likely to be less dramatic, and the defects associated with
DIABLOS71L will probably be subtle and accumulative
and only become pathological over time. This hypothesis
is consistent with the late onset and progressive nature
of hearing impairment in DFNA64. A mouse model that
expresses a mutant allele of DIABLOS71L in a DIABLOwt
background will be the next tool in the study of accumula-
tive effects and progressive hearing loss. Furthermore, it
remains to be determined which degradation pathway
DIABLOS71L activates.
Unveiling new molecular mechanisms of hearing
impairment might result in valuable insights into the
molecular triggers for hair cell degeneration and provide
the basis for genetic diagnosis as well as exciting develop-
ments in therapeutic intervention in hearing loss. Work
pioneered by Steven McKnight has shown that proneuro-
genic chemical P7C3 is able to preserve mitochondrial
membrane permeability by a yet unknown mechanism.21
Our results raise the possibility of utilizing mitochondria
protective compound (such as P7C3) for potential thera-
peutic benefit to protect hair cell mitochondrial membrane
potential and attenuate the progression of hearing loss in
DFNA64 individuals. This would represent a new direction
for possible intervention in progressive hearing loss among
the general deaf population.Supplemental Data
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